# Smallpox (Variola Virus) Infection: Developing Drugs for Treatment or Prevention Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/smallpox-variola-virus-infection-developing-drugs-for-treatment-or-prevention-guidance-for-industry/c6eb4d8b-888a-4dc5-bb4d-877f66f968fb

> FDA guidance document: Smallpox (Variola Virus) Infection: Developing Drugs for Treatment or Prevention Guidance for Industry. Issue date: November 18, 2019. Get complete insights and analysis.

---

## Details

- Title: Smallpox (Variola Virus) Infection: Developing Drugs for Treatment or Prevention Guidance for Industry
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2019-11-18
- Last Changed: 2020-05-04
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2018-D-1835">FDA-2018-D-1835</a>

## Related Documents

- [Recurrent Herpes Labialis:  Developing Drugs for Treatment and Prevention](https://www.globalkeysolutions.net/guidances/guidance-document/recurrent-herpes-labialis-developing-drugs-for-treatment-and-prevention/e4e0fd38-d19b-43b7-9f6b-13b91c093857)
- [Uncomplicated Urinary Tract Infections: Developing Drugs for Treatment Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/uncomplicated-urinary-tract-infections-developing-drugs-for-treatment-guidance-for-industry/c70a4ac7-4c57-4214-9174-25145ed55675)
- [Vulvovaginal Candidiasis:  Developing Drugs for Treatment](https://www.globalkeysolutions.net/guidances/guidance-document/vulvovaginal-candidiasis-developing-drugs-for-treatment/3c14a50c-15d0-4ad3-94ec-76a32afa2bdb)